Answer
Lenvatinib Eisai with pembrolizumab is indicated for adults with advanced or recurrent endometrial carcinoma whose disease has progressed on or following prior platinum-containing therapy in any setting and who are not candidates for curative surgery or radiation.
Sources for this answer
- Lenvatinib Eisai 4mg hard capsulesEisai Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 32Document updated
Sources checked